GuraKMLeeSValimC. Safety and efficacy of a fish oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics. 2008;121(3):e678-e686.
4.
de MeijerVEGuraKMLeHDMeiselJAPuderM.Fish oil–based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr. 2009;33(5):541-547.
5.
PuderMValimCMeiselJA. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009;250(3):395-402.
6.
de MeijerVEGuraKMMeiselJALeHDPuderM.Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease. Arch Surg. 2010;145(6):547-551.
7.
NandivadaPFellGLMitchellPD. Long-term fish oil lipid emulsion use in children with intestinal failure-associated liver disease [published online March9, 2016]. JPEN J Parenter Enteral Nutr.
8.
GuraKMPuderM.Rapid infusion of fish oil-based emulsion in infants does not appear to be associated with fat overload syndrome. Nutr Clin Pract. 2010;25(4):399-402.
9.
AlwaynIPGuraKNoseV. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res. 2005;57(3):445-452.
10.
AlwaynIPAnderssonCZauscherB. Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor. Transplantation. 2005;79(5):606-608.
11.
JavidPJGreeneAKGarzaJ. The route of lipid administration affects parenteral nutrition-induced hepatic steatosis in a mouse model. J Pediatr Surg. 2005;40(9):1446-1453.
12.
MeiselJALeHDde MeijerVE. Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model. J Pediatr Surg. 2011;46(4):666-673.
13.
KalishBTLeHDFitzgeraldJM. Intravenous fish oil lipid emulsion promotes a shift toward anti-inflammatory proresolving lipid mediators. Am J Physiol Gastrointest Liver Physiol. 2013;305(11):G818-G828.
